Related Experiment Video
Updated: Sep 5, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Aureoterrolides B‒M: Eremophilane-type sesquiterpenoids isolated from Aspergillus aureoterreus and their cytotoxicity
Yi Zang1, Beiping Zhou1, Mengsha Wei2
1Key Laboratory of Agricultural Microbiomics and Precision Application-Ministry of Agriculture and Rural Affairs, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, State Key Laboratory of Applied Microbiology Southern China, Guangdong Microbial Culture Center, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou, 510070, China.
Abstract:
Uncovered by genome sequence analyses, twelve undescribed sesquiterpenoids designated aureoterrolides B‒M, were isolated from the culture broth of the fungus Aspergillus aureoterreus together with two known analogues. They are unusual eremophilanes with an oxidized C-4, of which aureoterrolide J is an unreported furanoeremophilane comprising a 3/6/6/5/3 pentacyclic architecture with a rare 3,6-spiro ring system. Their structures and absolute configurations were unambiguously assigned by extensive spectroscopic method and theoretical ECD calculation. All isolated compounds were evaluated their cytotoxicity, and aureoterrolides A, B, and I-K showed moderate cytotoxic activity against three human cancer cell lines (HL-60, HepG-2, and SKOV-3) with IC50 values ranging from 4.53 ± 0.05 to 24.71 ± 0.16 μM. Among them, aureoterrolide A exhibited activity such close to the positive control and apoptotic effect on HL-60 cells at a concentration of 5.0 μM.
Related Concept Videos
Physical Properties of Amines
Fungal Phylum Ascomycota
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

